FIXX has been in the penalty box since the FDA put a clinical hold on its lead program in 2022 (#msg-167944477), despite an updated protocol for the trial in question (#msg-169133433).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.